IL85905A0 - Immunogenic recombinant yeast expression product and method for purifying it - Google Patents

Immunogenic recombinant yeast expression product and method for purifying it

Info

Publication number
IL85905A0
IL85905A0 IL85905A IL8590588A IL85905A0 IL 85905 A0 IL85905 A0 IL 85905A0 IL 85905 A IL85905 A IL 85905A IL 8590588 A IL8590588 A IL 8590588A IL 85905 A0 IL85905 A0 IL 85905A0
Authority
IL
Israel
Prior art keywords
purifying
expression product
yeast expression
recombinant yeast
immunogenic recombinant
Prior art date
Application number
IL85905A
Other languages
English (en)
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of IL85905A0 publication Critical patent/IL85905A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL85905A 1987-03-30 1988-03-29 Immunogenic recombinant yeast expression product and method for purifying it IL85905A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3232687A 1987-03-30 1987-03-30

Publications (1)

Publication Number Publication Date
IL85905A0 true IL85905A0 (en) 1988-09-30

Family

ID=21864341

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85905A IL85905A0 (en) 1987-03-30 1988-03-29 Immunogenic recombinant yeast expression product and method for purifying it

Country Status (9)

Country Link
EP (1) EP0309555A4 (pt)
JP (1) JPH01503514A (pt)
AU (1) AU617668B2 (pt)
ES (1) ES2009587A6 (pt)
IL (1) IL85905A0 (pt)
NZ (1) NZ224086A (pt)
PT (2) PT87137B (pt)
WO (1) WO1988007546A1 (pt)
ZA (1) ZA882272B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
NZ213303A (en) * 1984-09-12 1988-09-29 Univ New York Plasmodium protein, dna sequence and vaccine
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine

Also Published As

Publication number Publication date
EP0309555A4 (en) 1990-04-10
ES2009587A6 (es) 1989-10-01
PT87137B (pt) 1992-07-31
PT87332B (pt) 1992-07-31
AU1593688A (en) 1988-11-02
JPH01503514A (ja) 1989-11-30
WO1988007546A1 (en) 1988-10-06
ZA882272B (en) 1988-09-22
NZ224086A (en) 1991-02-26
AU617668B2 (en) 1991-12-05
PT87137A (pt) 1988-04-01
PT87332A (pt) 1988-05-01
EP0309555A1 (en) 1989-04-05

Similar Documents

Publication Publication Date Title
GB8721424D0 (en) Recombinant expression method
AU588431B2 (en) Apparatus and method for continuous camlobe phasing
IL87815A (en) Packaging system and method
HUT46363A (en) Process for transforming human insulin-precursor into human insulin
AU2422388A (en) Simplified method and apparatus for purification
GR871294B (en) Oven product and preparation method therefor
JPS6434293A (en) Fermentation method
EP0280067A3 (en) Cyclic polycarbonate-polyepoxide reaction products and method for their preparation
ZA885301B (en) Process and apparatus for fermentation and uses thereof
AU7440087A (en) Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli
EG18005A (en) Composition of the activation of fermentative processes and process for the acceleration of the fermentative degradation of natural products
AU6524386A (en) Method for administering vaccines and compositions therefor
IL85905A0 (en) Immunogenic recombinant yeast expression product and method for purifying it
IL88321A0 (en) Sialocylglycerolipids and method for preparing same
YU6889A (en) Process for obtaining recombinant human interleukin-1-alpha-polypeptide
GB2220551B (en) Process and means for efficient photosynthesis
GB2239653B (en) Process and composition for the purification of amphotericin b
AU2051788A (en) An improved method and pharmaceutical composition
DE3790885D2 (en) Multicomputing system and process for driving same
ZA892167B (en) Method and apparatus for shaping antiperspirant sticks and similar products
EP0302331A3 (en) Esters of arylbisperfluoralkylcarbinols, method for the preparation of the same and of the arylbisperfluoralkylcarbinols in question
ZA859297B (en) Process and vaccine
IE880951L (en) Immunogenic recombinant yeast expression product and method¹for purifying it
IE880952L (en) Immunogenic recombinant yeast expression product
IE871212L (en) "process for isolating and purifying p. falciparum cs¹protein vaccine expressed in recombinant e. colt"